Skip to main content

Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology

  • Chapter
  • First Online:

Part of the book series: Progress in Drug Research ((PDR,volume 70))

Abstract

Bacteria represent the earliest form of independent life on this planet. Bacterial development has included cooperative symbiosis with plants (e.g., Leguminosae family and nitrogen fixing bacteria in soil) and animals (e.g., the gut microbiome). It is generally agreed upon that the fusion of two prokaryotes evolutionarily gave rise to the eukaryotic cell in which mitochondria may be envisaged as a genetically functional mosaic, a relic from one of the prokaryotes. This is expressed by the appearance of mitochondria in eukaryotic cells (an alpha-proteobacteria input), a significant endosymbiotic evolutionary event. As such, the evolution of human life has been complexly connected to bacterial activities. Hence, microbial colonization of mammals has been a progressively driven process. The interactions between the human host and the microbiome inhabiting the gastrointestinal tract (GIT) for example, afford the human host the necessary cues for the development of regulated signals that in part are induced by reactive oxygen species (ROS) . This regulated activity then promotes immunological tolerance and metabolic regulation and stability, which then helps establish control of local and extraintestinal end-organ (e.g., kidneys) physiology. Pharmacobiotics , the targeted administration of live probiotic cultures, is an advancing area of potential therapeutics, either directly or as adjuvants. Hence the continued scientific understanding of the human microbiome in health and disease may further lead to fine tuning the targeted delivery of probiotics for a therapeutic gain.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    A placebo is a substance containing no medication benefit and prescribed to reinforce a patient’s expectation of possibly attaining a beneficial effect.

References

  • Amaral FA, Sachs D, Costa VV et al (2008) Commensal microbiota is fundamental for the development of inflammatory pain. PNAS USA 105:2193–2197

    CAS  PubMed Central  PubMed  Google Scholar 

  • Arumugam M, Raes J, Pelletier E et al (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174–80.

    Google Scholar 

  • Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. NEJM 347(12):911–920

    PubMed  Google Scholar 

  • Backhead F, Manchester JK, Semenkovich CF, Gordon JI (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. PNAS USA 104:979–984

    Google Scholar 

  • Bailey DM, Raman S, McEnery J et al (2006) Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion. Free Radic Biol Med 40:591–600

    CAS  PubMed  Google Scholar 

  • Bauer H, Horowitz RE, Levenson SM et al (1963) The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am J Pathol 42:471–483

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bella CJ, Coulson S, Vitetta L (2014) Is co–prescribing a multi–strain probiotic the simple solution for treating and preventing Proton Pump Inhibitor (PPIs) induced Clostridium difficile Associated Diarrhoea (CDAD) while maintaining evidence based pharmacotherapy? Submitted Adv Integr Med 1:52–54

    Google Scholar 

  • Bengmark S, Martindale R (2005) Prebiotics and synbiotics in clinical medicine. Nutr Clin Pract 20(2):244–261

    PubMed  Google Scholar 

  • Berg RD, Savage DC (1975) Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms. Infect Immun 11(2):320–329

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S et al (2012) Probiotic mechanisms of action. Ann Nutr Metab 61(2):160–174

    CAS  PubMed  Google Scholar 

  • Borody TJ, Campbell J (2012) Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin North Am 41(4):781–803

    PubMed  Google Scholar 

  • Bota DA, Van Remmen H, Davies KJ (2002) Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 532(1–2):103–106

    CAS  PubMed  Google Scholar 

  • Bota DA, Ngo JK, Davies KJ (2005) Down regulation of the human Lon protease impairs mitochondrial structure and function and causes cell death. Free Radic Biol Med 38(5):665–677

    CAS  PubMed  Google Scholar 

  • Bouilly-Gauthier D, Jeannes C, Maubert Y et al (2010) Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage. Br J Dermatol 163:536–543

    CAS  PubMed  Google Scholar 

  • Buddington RK, Williams CH, Chen SC et al (1996) Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63(5):709–716

    CAS  PubMed  Google Scholar 

  • Caselli M, Vaira G, Calo G et al (2011) Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr 2:372–376

    CAS  PubMed Central  PubMed  Google Scholar 

  • Chapman CM, Gibson GR, Rowland I (2011) Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr 50(1):1–17

    CAS  PubMed  Google Scholar 

  • Chiang CK, Tanaka T, Nangaku M (2012) Dysregulated oxygen metabolism of the kidney by uremic toxins: review. J Ren Nutr 22(1):77–80

    CAS  PubMed  Google Scholar 

  • Cert-Bensussan N, Gaboriau-Routhiau V (2010) The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10(10):735–744

    Google Scholar 

  • Chen Q, Krishna Espey MG et al (2005) Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 102:13604–13609

    CAS  PubMed Central  PubMed  Google Scholar 

  • Chorell E, Karlsson Videhult F, Hernell O et al (2013) Impact of probiotic feeding during weaning on the serum lipid profile and plasma metabolome in infants. Br J Nutr 110:116–126

    CAS  PubMed  Google Scholar 

  • Cicek M, Yıldırır A, Okyay K et al (2013) Use of alpha-lipoic acid in prevention of contrast-induced nephropathy in diabetic patients. Ren Fail 35(5):748–753

    CAS  PubMed  Google Scholar 

  • Cimperman L, Bayless G, Best K et al (2011) A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 45(9):785–789

    PubMed  Google Scholar 

  • Collier-Hyams LS, Sloane V, Batten BC, Neish AS (2005) Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J Immunol 175(7):4194–4198

    CAS  PubMed  Google Scholar 

  • de Vrese M, Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111:1–66

    PubMed  Google Scholar 

  • Ding S, Lund PK (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 14:328–333

    CAS  PubMed Central  PubMed  Google Scholar 

  • Dolan MF, Margulis L (2007) Advances in biology reveal truth about prokaryotes. Nature 445(7123):21

    CAS  PubMed  Google Scholar 

  • Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. PNAS 107:11971–11975

    PubMed Central  PubMed  Google Scholar 

  • Dounousi E, Papavasiliou E, Makedou A et al (2006) Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 48:752–760

    CAS  PubMed  Google Scholar 

  • Drouault-Holowacz S, Bieuvelet S, Burckel A et al (2008) A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 32(2):147–152

    CAS  PubMed  Google Scholar 

  • Eckmann L (2006) Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 22(2):95–101

    CAS  PubMed Central  PubMed  Google Scholar 

  • Enck P, Zimmermann K, Menke G et al (2008) A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome–a randomized controlled trial with primary care physicians. Neurogastroenterol Motil 20(10):1103–1109

    CAS  PubMed  Google Scholar 

  • Farout L, Friguet B (2006) Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid Redox Signal 8:205–216

    CAS  PubMed  Google Scholar 

  • Fuller R (1989) Probiotics in man and animals. J Appl Bacteriol 66(5):365–378

    CAS  PubMed  Google Scholar 

  • Fuss IJ, Neurath M, Boirivant M et al (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157(3):1261–1270

    CAS  PubMed  Google Scholar 

  • Giaffer MH, Holdsworth CD, Duerden BI (1991) The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 35(4):238–243

    CAS  PubMed  Google Scholar 

  • Giovannini M, Agostoni C, Riva E et al (2007) Felicita study group. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 62(2):215–220

    PubMed  Google Scholar 

  • Grice EA, Segre JA (2011) The skin microbiome. Nat Rev Microbiol 9(4):244–253

    CAS  PubMed Central  PubMed  Google Scholar 

  • Heller F, Florian P, Bojarski C et al (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterol 129(2):550–564

    CAS  Google Scholar 

  • Hickson M (2011) Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol 4(3):185–197

    CAS  PubMed Central  PubMed  Google Scholar 

  • Himmelfarb J, Stenvinkel P, Ikizler TA et al (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524–1538

    CAS  PubMed  Google Scholar 

  • Hooper LV (2004) Bacterial contributions to mammalian gut development. Trends Microbiol 12:129–134

    CAS  PubMed  Google Scholar 

  • Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10(3):159–169

    CAS  PubMed  Google Scholar 

  • Hornig D (1975) Distribution of ascorbic acid, metabolites and analogues in man and animals. Ann NY Acad Sci 258:103–118

    CAS  PubMed  Google Scholar 

  • Husom AD, Peters EA, Kolling EA et al (2004) Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys 421(1):67–76

    Google Scholar 

  • Hussaarts L, van der Vlugt LE, Yazdanbakhsh M, Smits HH (2011) Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 128(4):733–739

    CAS  PubMed  Google Scholar 

  • Hvas CL, Kelsen J, Agnholt J et al (2007) Crohn’s disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria. Scand J Gastroenterol 42(5):592–601

    CAS  PubMed  Google Scholar 

  • Jun M (2013) Antioxidants for chronic kidney disease. Nephrology Carlton 18:576–578

    PubMed  Google Scholar 

  • Kadooka Y, Sato M, Imaizumi K et al (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64:636–643

    CAS  PubMed  Google Scholar 

  • Kajander K, Hatakka K, Poussa T et al (2005) A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 22(5):387–394

    CAS  PubMed  Google Scholar 

  • Kajander K, Myllyluoma E, Rajilic-Stojanovic M et al (2008) Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 27(1):48–57

    CAS  PubMed  Google Scholar 

  • Kim HJ, Camilleri M, McKinzie S et al (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17(7):895–904

    CAS  PubMed  Google Scholar 

  • Kim HJ, Vazquez Roque MI, Camilleri M et al (2005) A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 17(5):687–696

    CAS  PubMed  Google Scholar 

  • Lee WJ (2008) Bacterial-modulated signaling pathways in gut homeostasis. Sci Signal 1(21):pe24

    Google Scholar 

  • Lee HJ, Waller RD, Stebbings S et al (2010) The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study. Int J Rheum Dis 13:48–54

    PubMed  Google Scholar 

  • Ley RE, Hamady M, Lozupone C et al (2008) Evolution of mammals and their gut microbes. Science 320:1647–1651

    CAS  PubMed Central  PubMed  Google Scholar 

  • Li S, Taylor KB, Kelly SJ, Jedrzejas MJ (2001) Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase. J Biol Chem 276(18):15125–15130

    CAS  PubMed  Google Scholar 

  • Lin PW, Myers LE, Ray L et al (2009a) Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 47(8):1205–1211

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lin JS, Chiu YH, Lin NT et al (2009b) Different effects of probiotic species/strains on infections in preschool children: a double-blind, randomized, controlled study. Vaccine 27(7):1073–1079

    PubMed  Google Scholar 

  • Linnane AW, Kios M, Vitetta L (2007) Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide. Biogerontology 8(5):445–467

    CAS  PubMed  Google Scholar 

  • Loguercio C, de Simone T, Federico A et al (2002) Gut-liver axis: A new point of attack to treat chronic liver damage? Am J Gastroenterol 97:2144–2146

    PubMed  Google Scholar 

  • Luoto R, Kalliomaki M, Laitinen K, Isolauri E (2010) The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) 34:1531–1537

    CAS  Google Scholar 

  • MacDonald TT, di Sabatino A (2006) The exposure of infants to Lactobacillus rhamnosus GG in Finland. J Pediatr Gastroenterol Nutr 42:476–478

    PubMed  Google Scholar 

  • Mackay IR, Rosen FS, Zinkernagel RM (2001) Maternal antibodies, childhood infections, and autoimmune diseases. NEJM 345(18):1331–1335

    Google Scholar 

  • Martin HM, Campbell BJ, Hart CA et al (2004) Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology 127:80–93

    CAS  PubMed  Google Scholar 

  • Matsuoka K, Inoue N, Sato T et al (2004) T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease. Gut 53(9):1303–1308

    CAS  PubMed Central  PubMed  Google Scholar 

  • Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107–118

    CAS  PubMed  Google Scholar 

  • Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620–625

    CAS  PubMed  Google Scholar 

  • Meiners S, Heyken D, Weller A et al (2003) Inhibition of proteasome induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J Biol Chem 278:21517–21525

    CAS  PubMed  Google Scholar 

  • Mencarelli A, Distrutti E, Renga B et al (2011) Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS ONE 6(7):e22978

    CAS  PubMed Central  PubMed  Google Scholar 

  • Morelli L, Capurso L (2012) FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol 46 Suppl:S1-2

    Google Scholar 

  • Mylonaki M, Rayment NB, Rampton DS et al (2005) Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 11(5):481–487

    PubMed  Google Scholar 

  • Nakamura YK, Omaye ST (2012) Metabolic diseases and pro- and prebiotics: mechanistic insights. Nutr Metab (Lond) 9:60

    CAS  Google Scholar 

  • Neish AS (2013) Redox signaling mediated by the gut microbiota. Free Radic Res (Epub ahead of print)

    Google Scholar 

  • Neish AS, Gewirtz AT, Zeng H et al (2000) Prokaryotic regulation of epithelial responses by inhibition of Ikappa B-alpha ubiquitination. Science 289:1560–1563

    CAS  PubMed  Google Scholar 

  • Niedzielin K, Kordecki H, Birkenfeld B (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299 V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13(10):1143–1147

    CAS  PubMed  Google Scholar 

  • Niv E, Naftali T, Hallak R, Vaisman N (2005) The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome–a double blind, placebo-controlled, randomized study. Clin Nutr 24(6):925–931

    PubMed  Google Scholar 

  • Nunbhakdi-Craig V, Machleidt T, Ogris E et al (2002) Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 158(5):967–978

    CAS  PubMed Central  PubMed  Google Scholar 

  • O’Mahony L, McCarthy J, Kelly P et al (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128(3):541–551

    PubMed  Google Scholar 

  • O’Neill LA (2006) How Toll-like receptors signal: what we know and what we don’t know. Curr Opin Immunol 18:3–9

    PubMed  Google Scholar 

  • Parassol N, Freitas M, Thoreux K et al (2005) Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 156(2):256–262

    CAS  PubMed  Google Scholar 

  • Pasare C, Medzhitov R (2004) Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21:733–741

    CAS  PubMed  Google Scholar 

  • Patel RM, Myers LS, Kurundkar AR et al (2012) Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol 180(2):626–635

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pereira DI, Gibson GR (2002) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68:4689–4693

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pickering GW (1950) Significance of the discovery of the effects of cortisone on rheumatoid arthritis. Lancet 6620–6621

    Google Scholar 

  • Pineiro M, Stanton C (2007) Probiotic bacteria: legislative framework—requirements to evidence basis. J Nutr 137(3 Suppl 2):850S–853S

    CAS  PubMed  Google Scholar 

  • Polson J, Lee WM (2005) AASLD position paper: The management of acute liver failure. Hepatology 41:1179–1197

    PubMed  Google Scholar 

  • Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118(2):229–241

    CAS  PubMed  Google Scholar 

  • Rautava S, Luoto R, Salminen S, Isolauri E (2012) Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol 9(10):565–576

    CAS  PubMed  Google Scholar 

  • Rossi O, van Baarlen P, Wells JM (2013) Host-recognition of pathogens and commensals in the mammalian intestine. Curr Top Microbiol Immunol 358:291-321

    Google Scholar 

  • Rutkowski P, Słominska EM, Szołkiewicz M et al (2007) Relationship between uremic toxins and oxidative stress in patients with chronic renal failure. Scand J Urol Nephrol 41(3):243–248

    CAS  PubMed  Google Scholar 

  • Safavi M, Farajian S, Kelishadi R et al (2013) The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial. Int J Food Sci Nutr 64:687–693

    CAS  PubMed  Google Scholar 

  • Schneeberger EE, Lynch RD (2004) The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286(6):C1213–C1228

    CAS  PubMed  Google Scholar 

  • Scholz-Ahrens KE, Ade P, Marten B et al (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137(3 Suppl 2):838S–846S

    CAS  PubMed  Google Scholar 

  • Sha S, Liang J, Chen M, Xu B, Liang C, Wei N, Wu K (2014) Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther 39(10):1003–1032

    CAS  PubMed  Google Scholar 

  • Shih PM, Matzke NJ (2013) Primary endosymbiosis events date to the later Proterozoic with cross-calibrated phylogenetic dating of duplicated ATPase proteins. Proc Natl Acad Sci USA 110(30):12355–12360

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sinn DH, Song JH, Kim HJ et al (2008) Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 53(10):2714–2718

    PubMed  Google Scholar 

  • Singel DJ, Stamler JS (2005) Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrohemoglobin. Ann Rev Physiol 67:99–145

    CAS  Google Scholar 

  • Sironi M, Clerici M (2010) The hygiene hypothesis: an evolutionary perspective. Microbes Infect 12(6):421–427

    PubMed  Google Scholar 

  • So JS, Song MK, Kwon HK et al (2011) Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis. Life Sci 88:358–366

    CAS  PubMed  Google Scholar 

  • Stolze IP, Mole DR, Ratcliffe PJ (2006) Regulation of HIF: prolyl hydroxylases. Novartis Found Symp 272:15–25

    CAS  PubMed  Google Scholar 

  • Sun H, Gao J, Ferrington DA et al (1999) Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase. Biochemistry 38:105–112

    CAS  PubMed  Google Scholar 

  • Swidsinski A, Ladhoff A, Pernthaler A et al (2002) Mucosal flora in inflammatory bowel disease. Gastroenterol 122(1):44–54

    Google Scholar 

  • Tan M, Zhu JC, Du J et al (2011) Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Crit Care 15:R290

    PubMed Central  PubMed  Google Scholar 

  • Tappenden KA, Deutsch AS (2007) The physiological relevance of the intestinal microbiota-contributions to human health. JACN 26(6):679S–683S

    Google Scholar 

  • Terawaki H, Yoshimura K, Hasegawa T et al (2004) Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 66(5):1988–1993

    CAS  PubMed  Google Scholar 

  • Tien MT, Girardin SE, Regnault B et al (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176:1228–1237

    CAS  PubMed  Google Scholar 

  • Van de Merwe JP, Schroder AM, Wensinck F et al (1988) The obligate anaerobic faecal flora of patients with Crohn’s disease and their first-degree relatives. Scand J Gastroenterol 23(9):1125–1131

    PubMed  Google Scholar 

  • Vanholder R, De Smet R, Glorieux G et al (2003) Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63:1934–1943

    CAS  PubMed  Google Scholar 

  • Van Nood E, Vrieze A, Nieuwdorp M et al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368:407–415

    PubMed  Google Scholar 

  • Vaziri ND, Yuan J, Rahimi A, Subramanian VS et al (2012) Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transp 27:2686–2693

    CAS  Google Scholar 

  • Vinik A (2011) The question is, my dear watson, why did the dog not bark? the joslin 50-year medalist study. Diabetes Care 34(4):1060–1063

    PubMed Central  PubMed  Google Scholar 

  • Vitetta L, Alford H (2013) The pharmacobiotic potential of the gastrointestinal tract micro-biometabolome–probiotic connect: a brief commentary. Drug Dev Res 74(6):353–359

    CAS  Google Scholar 

  • Vitetta L, Gobe G (2013) Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics. Mol Nutr Food Res 57:824–832

    CAS  PubMed  Google Scholar 

  • Vitetta L, Sali A (2008) Probiotics, prebiotics and gastrointestinal health. Med Today 9:65–70

    Google Scholar 

  • Vitetta L, Briskey D, Hayes E, Shing C, Peake J (2012) A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacol 20(5):251–66

    Google Scholar 

  • Vitetta L, Briskey D, Alford H, Hall S, Coulson S (2014a) Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology 22(3):135–154

    Google Scholar 

  • Vitetta L, Manuel R, Zhou JY, Linnane AW, Hall S, Coulson S (2014b) The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures. Pharmaceuticals (Basel) 7(9):954–989

    Google Scholar 

  • Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69–75

    CAS  PubMed  Google Scholar 

  • Whorwell PJ, Altringer L, Morel J et al (2006) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101(7):1581–1590

    PubMed  Google Scholar 

  • Wu JT, Lin HC, Hu YC, Chien CT (2005) Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat Cell Biol 7(10):1014–1020

    CAS  PubMed  Google Scholar 

  • Xu J, Gordon JI (2003) Honor thy symbionts. PNAS 100:10452–10459

    CAS  PubMed Central  PubMed  Google Scholar 

  • Yan F, Cao H, Cover TL et al (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132(2):562–575

    CAS  PubMed Central  PubMed  Google Scholar 

  • Yin D, Sun H, Weaver RF, Squier TC (1999) Nonessential role for methionines in the productive association between calmodulin and the plasma membrane Ca-ATPase. Biochemistry 38:13654–13660

    CAS  PubMed  Google Scholar 

  • Yin D, Kuczera K, Squier TC (2000) The sensitivity of carboxyl-terminal methionines in calmodulin isoforms to oxidation by H2O2 modulates the ability to activate the plasma membrane Ca-ATPase. Chem Res Toxicol 13:103–110

    CAS  PubMed  Google Scholar 

  • Zarrati M, Shidfar F, Nourijelyani K et al (2013) Lactobacillus acidophilus La5, Bifidobacterium BB12, and Lactobacillus casei DN001 modulate gene expression of subset specific transcription factors and cytokines in peripheral blood mononuclear cells of obese and overweight people. BioFactors 39:633–643

    CAS  PubMed  Google Scholar 

  • Zeng J, Li YQ, Zuo XL et al (2008) Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable Bowel syndrome. Aliment Pharmacol Ther 28(8):994–1002

    CAS  PubMed  Google Scholar 

  • Zyrek AA, Cichon C, Helms S et al (2007) Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9:804–816

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments/Conflict of Interest

Luis Vitetta has received National Institute of Complementary Medicine and National Health and Medical Research Council of Australia competitive funding and industry support for research into probiotics. The authors have no further conflicts of interest relevant to the content of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luis Vitetta .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Basel

About this chapter

Cite this chapter

Vitetta, L., Palacios, T., Hall, S., Coulson, S. (2015). Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology. In: Rainsford, K., Powanda, M., Whitehouse, M. (eds) Novel Natural Products: Therapeutic Effects in Pain, Arthritis and Gastro-intestinal Diseases. Progress in Drug Research, vol 70. Springer, Basel. https://doi.org/10.1007/978-3-0348-0927-6_1

Download citation

Publish with us

Policies and ethics